Cargando…
Targeting LRH-1 in hepatoblastoma cell lines causes decreased proliferation
Hepatoblastoma is the most common malignant liver tumor in children. Since it is often unresectable and exhibits drug resistance, the treatment of advanced hepatoblastoma is challenging. The orphan nuclear receptor liver receptor homolog-1 (LRH-1) serves prominent roles in malignancy; however, to th...
Autores principales: | Jin, Jingling, Jin, Junliang, Woodfield, Sarah E., Patel, Roma H., Jin, Nan Ge, Shi, Yan, Liu, Bin, Sun, Wenjing, Chen, Xiangmei, Yu, Yang, Vasudevan, Sanjeev A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278492/ https://www.ncbi.nlm.nih.gov/pubmed/30320362 http://dx.doi.org/10.3892/or.2018.6793 |
Ejemplares similares
-
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2017) -
Surgical Management of Hepatoblastoma and Recent Advances
por: Yang, Tianyou, et al.
Publicado: (2019) -
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021) -
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021) -
Identification of transcription factors and single nucleotide polymorphisms of Lrh1 and its homologous genes in Lrh1-knockout pancreas of mice
por: Tang, Maochun, et al.
Publicado: (2014)